AA
WST icon

Alta Advisers’s West Pharmaceutical WST Stock Holding History

Alta Advisers’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-300
Closed -$90K – 405
2024
Q3 		$90K Hold
300
– – 0.04% 319
2024
Q2 		$98.8K Hold
300
– – 0.05% 265
2024
Q1 		$119K Hold
300
– – 0.06% 239
2023
Q4 		$106K Hold
300
– – 0.06% 243
2023
Q3 		$113K Hold
300
– – 0.07% 207
2023
Q2 		$115K Hold
300
– – 0.06% 203
2023
Q1 		$104K Hold
300
– – 0.06% 223
2022
Q4 		$71K Hold
300
– – 0.04% 322
2022
Q3 		$74K Buy
+300
New +$91.4K 0.05% 290

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Alta Advisers's WST Position: Q4 2024 in Review

Alta Advisers sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 300 shares — an estimated $90K sold.

Alta Advisers first reported a position in WST in Q3 2022 and held it in 9 quarters. The position peaked at $119K in Q1 2024. 748 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • Alta Advisers reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Alta Advisers sold 300 West Pharmaceutical shares in Q4 2024, an estimated $90K.
  • Alta Advisers first reported a position in West Pharmaceutical in Q3 2022 and held it in 9 quarters.
  • Alta Advisers's West Pharmaceutical position peaked at $119K in Q1 2024.
  • 748 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on Alta Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.